MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-KR-03-0106773
Beloorbayir Biotech Limited - pharma in Bangalore, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2021
₹67.42 Cr
▼ 4% YoY
Net loss · FY 2021
₹1.53 Cr
Net margin -2.3%
EBITDA · FY 2021
₹7.6 Cr
EBITDA margin 11.3%
Authorised capital
₹67 Cr
Registered with MCA
Paid-up capital
₹39.94 Cr
Issued & subscribed
Open charges
₹55.44 Cr
Satisfied ₹51.27 Cr
Company age
21 yrs
Est. 2005
Employees · EPFO
110
Provident fund records
About Beloorbayir Biotech Limited
Data last updated:
Beloorbayir Biotech Limited is a public limited company based in Bangalore, Karnataka, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 02 March 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U73100KA2005PLC035741. Its GSTIN is 29AACCB6949C2ZK (Karnataka). The company holds 8 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹67 Cr and a paid-up capital of ₹39.94 Cr. It is led by directors including Beloor Ganapayya Bairy (Managing Director) and Ajay Ganapayya Bairy (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2021. The registered office is at # 4112 Utkarsha K R Road Banashankari 2nd Stage, Bangalore, Karnataka, India – 560070.
As per the financials filed for FY 2021, the company reported a revenue of ₹67.42 Cr, a decline of 4% compared to the previous year. For the same year it recorded a net loss of ₹1.53 Cr (net margin -2.3%) and EBITDA of ₹7.6 Cr (EBITDA margin 11.3%). Revenue has declined at a compounded annual rate (CAGR) of 20% over three years and 7% over five years.
The company has about 110 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Beloorbayir. As per MCA filings, the company has open charges of ₹55.44 Cr and satisfied charges of ₹51.27 Cr on record. Court records list 66 cases involving the company, including 25 filed by the company and 41 filed against it; 11 cases are pending. The company has 12 deals on record (8 funding rounds, 4 secondary share transfers), with disclosed funding of ₹87.59 Cr; the latest was in March 2017. Its 9 peer companies in the Pharma industry (API Manufacturers, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 4 smaller; the largest is Sanmar Speciality Chemicals Limited with revenue of ₹68.48 Cr.
Beloorbayir Biotech Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0106773). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website beloorbayir.com.
Company details
CIN U73100KA2005PLC035741
Registration Number 035741
Incorporation Date 02 March 2005
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2021
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-KR-03-0106773
Key People
Beloor Ganapayya Bairy Managing Director Ajay Ganapayya Bairy Whole-Time Director Veena Beloor Ganapayya Bairy Director Recognitions & Rankings of Beloorbayir Biotech
Contact details
Beloorbayir Biotech Limited's registered office is in Bangalore, Karnataka. Its website is beloorbayir.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address# 4112 Utkarsha K R Road Banashankari 2nd Stage, Bangalore, Karnataka, India – 560070
- IndustryPharma, API Manufacturers
To see the full contact details of Beloorbayir Biotech Limited, buy the company report.
Comprehensive company report
Beloorbayir Biotech Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Beloorbayir Biotech operates one associated brand: Beloorbayir. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Active pharmaceutical ingredients and nutraceuticals are manufactured and marketed. | beloorbayir.com |
Business activity
The main business activity of Beloorbayir Biotech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Beloorbayir Biotech Limited, buy the company report.
Financials of Beloorbayir Biotech Limited
FY 2021 filings availableBeloorbayir Biotech Limited reported revenue of ₹67.42 Cr (down 4% YoY) for FY 2021.
Revenue · FY 2021
₹67.42 Cr ▼ 4%
Net loss · FY 2021
₹1.53 Cr margin -2.3%
EBITDA · FY 2021
₹7.6 Cr margin 11.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 4%
3 years · compounded
▼ 20%
5 years · compounded
▼ 7%
EBITDA CAGR growth
1 year
▼ 7%
3 years · compounded
▼ 11%
5 years · compounded
▼ 16%
Revenue has declined at a compounded annual rate (CAGR) of 7% over five years, including a 4% fall in the latest year. EBITDA fell 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.6 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.53 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.3% | ||||
| Net Profit Margin | -2.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Beloorbayir Biotech Limited, buy the company report.
Board of directors of Beloorbayir Biotech Limited
Beloorbayir Biotech has 5 current directors and 16 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Veena Beloor Ganapayya Bairy Also directs: Bayir Extracts Private Limited | Director | 02 Mar 2005 | 21 Years 8 Months | Current |
| Ashok Sinha Also directs: Management Gyan LLP | Director | 28 Mar 2015 | 11 Years 7 Months | Current |
| Arvind Raghavan | Director | 28 Mar 2015 | 11 Years 7 Months | Current |
| Ajay Ganapayya Bairy Also directs: Emmune Health Care Private Limited, Bayir Extracts Private Limited | Whole-Time Director | 02 Mar 2005 | 21 Years 8 Months | Current |
| Beloor Ganapayya Bairy | Managing Director | 02 Mar 2005 | 21 Years 8 Months | Current |
Peer comparison
Beloorbayir Biotech Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (API Manufacturers, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sanmar Speciality Chemicals Limited | ₹68.48 Cr (FY 2018) | 11.0% | Chennai, Tamil Nadu, India | |||
| Merit Organics Limited | ₹68.45 Cr (FY 2025) | -5.0% | Mumbai, Maharashtra, India | |||
| Super Lifecare Private Limited | ₹68.31 Cr (FY 2025) | -16.0% | Ahmedabad, Gujarat, India | |||
| Lohitha Life Sciences Private Limited | ₹67.8 Cr (FY 2024) | 7.0% | Hyderabad, Telangana, India | |||
| Oxford Laboratories Private Limited | ₹67.77 Cr (FY 2025) | 26.0% | Mumbai, Maharashtra, India | |||
| Beloorbayir Biotech Limitedthis company | ₹67.42 Cr (FY 2021) | -₹1.53 Cr | -2.3% | -4.0% | 110 | Bangalore, Karnataka, India |
| Satyadivis Pharmaceuticals Private Limited | ₹67.35 Cr (FY 2024) | 2.0% | Jinnaram, Telangana, India | |||
| United Bioceuticals Private Limited | ₹67.35 Cr (FY 2024) | 31.0% | New Delhi, Delhi, India | |||
| Nakoda Chemicals Ltd | ₹67.34 Cr (FY 2025) | 25.0% | Hyderabad, Telangana, India | |||
| La Chandra Pharmalab Private Limited | ₹67.31 Cr (FY 2025) | 40.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Beloorbayir Biotech Limited, buy the company report.
Auditor
Beloorbayir Biotech Limited is audited by S UMESH & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S UMESH & CO | FY 2020 | 016240S |
Shareholding
The shareholding of Beloorbayir Biotech Limited is on record for 5 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2018 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Beloorbayir Biotech Limited, buy the company report.
Charges & borrowings
Open charges
₹55.44 Cr
Satisfied charges
₹51.27 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Nov 2016 | 100070441 | Hdfc Bank Limited | ₹3 Cr | Open | |
| 21 Mar 2016 | 100040567 | Hdfc Bank Limited | ₹10 Cr | Open | |
| 04 Jul 2014 | 10537549 | Others | ₹42.44 Cr | Open | |
| 26 Jul 2010 | 10252189 | Idbi Bank Limited | ₹27.78 Cr | Satisfied | |
| 21 Mar 2005 | 80027608 | Indianoverseasbank | ₹23.49 Cr | Satisfied |
To see the full charge records of Beloorbayir Biotech Limited, buy the company report.
Total charge records: 5 View all charges
Deals & funding
Beloorbayir Biotech Limited has 12 deals on record (8 funding rounds, 4 secondary share transfers), with disclosed funding of ₹87.59 Cr; the latest was in March 2017.
Total deals
12
Funding rounds
8
Secondary share transfers
4
Disclosed funding
₹87.59 Cr
Deals on record (5 of 12)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2017 | Funding round | ₹15 Cr | Investors: Rabo Equity Advisors |
| Nov 2016 | Funding round | ₹9.98 Cr | Investors: 2 individuals |
| Mar 2016 | Funding round | ₹74.3 Lakh | Investors: 2 individuals |
| Aug 2013 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Bayir Extracts Private Limited |
| Mar 2013 | Funding round | ₹2.63 Cr | Investors: Bayir Extracts Private Limited , 2 individuals |
To see the full deal history of Beloorbayir Biotech Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Beloorbayir Biotech Limited has 66 court cases on record: 25 filed by Beloorbayir Biotech, 41 filed against it. 11 cases are pending and 55 are disposed.
Total cases
66
Filed by the company
25
Filed against the company
41
Pending
11
Disposed
55
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 54 | 32 | 9 |
| High courts | 7 | 4 | 2 |
| NCLT | 5 | 5 | 0 |
Cases on record (5 of 66)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Indore, Madhya Pradesh | Court case (SC NIA) | Filed against the company by Medi-Caps Ltd. Through Rajendra | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (SS CASES S) | Filed against the company by Alliance Through Jayesh Shah | Pending |
| District court, Indore, Madhya Pradesh | Court case (UN CR) | Filed against the company by Medicaps Ltd. Through Rajendra Sharma | Pending |
| NCLT, Bengaluru | Insolvency matter | Filed against the company by Orix Leasing & Financial Services Indialimited | Disposed |
| District court, BENGALURU, Karnataka | Criminal miscellaneous application | Filed against the company by Union Bank of India Rep.By.Mahalinga | Disposed |
To see the full case history of Beloorbayir Biotech Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Beloorbayir Biotech Limited was last rated by Crisil on 06 Nov 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 06 Nov 2020 |
To see the full credit ratings and regulatory alerts of Beloorbayir Biotech Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Beloorbayir Biotech Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Beloorbayir Biotech Limited has a workforce of 110 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
Employee count
110
Active EPFO establishments
1
Employee growth
-2.65%
GST
Beloorbayir Biotech has 8 GST registrations: 1 active and 7 cancelled or inactive.
Total GSTINs
8
Active
1
Cancelled / inactive
7
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AACCB6949C2ZK | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Beloorbayir Biotech Limited, buy the company report.
Recent activity
Beloorbayir Biotech Limited has 17 board changes on record since 2005: 5 appointments and 12 cessations. The latest: Suneet Gupta ceased to be Nominee Director on 24 Nov 2021.
AGM
Beloorbayir Biotech Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Ceased
Suneet Gupta ceased to be Nominee Director.
Ceased
Venkatraman Subramanian ceased to be Nominee Director.
Filing
Beloorbayir Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Bangalore.
Charges
A charge with Others of Rs. 42.44 Cr registered on 04 Jul 2014 with Charge ID 10537549 was modified on 29 Dec 2020.
Ceased
Rajesh Kumar Srivastava ceased to be Nominee Director.
Ceased
Arvinder Singh Sodhi ceased to be Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 3.00 Cr with Charge ID 100070441 was registered on 28 Nov 2016.
Charges
A charge with Hdfc Bank Limited of Rs. 10.00 Cr registered on 21 Mar 2016 with Charge ID 100040567 was modified on 26 May 2016.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 10.00 Cr with Charge ID 100040567 was registered on 21 Mar 2016.
Ceased
Arvind Raghavan ceased to be Additional Director.
Ceased
Ashok Sinha ceased to be Additional Director.
19 earlier events are in the company report.
Frequently asked questions
Beloorbayir Biotech is an active public limited company based in Bangalore, Karnataka, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 02 March 2005 (21+ years old) and is registered under CIN U73100KA2005PLC035741.
Beloorbayir Biotech has 5 current directors:
- Beloor Ganapayya Bairy - Managing Director
- Ajay Ganapayya Bairy - Whole-Time Director
- Veena Beloor Ganapayya Bairy - Director
- Ashok Sinha - Director
- Arvind Raghavan - Director
The latest financial statements of Beloorbayir Biotech on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Beloorbayir Biotech is 29AACCB6949C2ZK, registered in Karnataka. The company has 8 GST registrations in all, of which 1 is active and 7 are cancelled or inactive.
The CIN (Corporate Identification Number) of Beloorbayir Biotech is U73100KA2005PLC035741. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Beloorbayir Biotech has 66 court cases on record: 25 filed by the company and 41 filed against it. 11 are pending. Most are in the district courts.
Beloorbayir Biotech was incorporated on 02 March 2005, making it 21+ years old. It is registered with the Registrar of Companies, Bangalore.
Beloorbayir Biotech has 12 deals on record (8 funding rounds, 4 secondary share transfers), with disclosed funding of ₹87.59 Cr; the latest was in March 2017.
The peers of Beloorbayir Biotech by revenue are Sanmar Speciality Chemicals Limited, Merit Organics Limited, Super Lifecare Private Limited, Lohitha Life Sciences Private Limited, Oxford Laboratories Private Limited and 4 more, all in the Pharma industry (API Manufacturers, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Suneet Gupta ceased to be Nominee Director on 24 Nov 2021. Venkatraman Subramanian ceased to be Nominee Director on 24 Nov 2021. Rajesh Kumar Srivastava ceased to be Nominee Director on 06 Feb 2018. Beloorbayir Biotech has 17 board changes on record in total.
Yes, Beloorbayir Biotech is registered as a medium enterprise under Udyam registration (number: UDYAM-KR-03-0106773).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages